CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Rhythm Pharmaceuticals Inc - RYTM CFD

48.89
0.59%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.26
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-0.26)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.04)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 50.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 49.18
Open 48.99
1-Year Change 90.77%
Day's Range 47.6 - 48.99
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 11, 2024 49.18 1.02 2.12% 48.16 49.44 47.00
Sep 10, 2024 49.05 -1.50 -2.97% 50.55 50.64 48.12
Sep 9, 2024 50.62 1.39 2.82% 49.23 50.92 49.19
Sep 6, 2024 49.19 1.99 4.22% 47.20 49.47 47.20
Sep 5, 2024 48.24 1.40 2.99% 46.84 48.26 46.27
Sep 4, 2024 46.80 1.83 4.07% 44.97 46.87 44.95
Sep 3, 2024 45.83 -0.65 -1.40% 46.48 47.56 45.09
Aug 30, 2024 47.23 1.63 3.57% 45.60 47.30 45.60
Aug 29, 2024 45.95 -0.50 -1.08% 46.45 47.19 45.62
Aug 28, 2024 46.32 -0.69 -1.47% 47.01 47.40 45.57
Aug 27, 2024 47.37 -2.06 -4.17% 49.43 49.44 46.94
Aug 26, 2024 49.90 3.74 8.10% 46.16 50.01 46.16
Aug 23, 2024 46.06 1.78 4.02% 44.28 46.15 44.05
Aug 22, 2024 44.15 -0.80 -1.78% 44.95 45.39 43.48
Aug 21, 2024 45.23 0.09 0.20% 45.14 46.52 45.06
Aug 20, 2024 45.52 -0.34 -0.74% 45.86 47.83 44.62
Aug 19, 2024 47.00 1.34 2.93% 45.66 47.25 45.66
Aug 16, 2024 45.99 -0.07 -0.15% 46.06 46.59 45.58
Aug 15, 2024 46.65 0.26 0.56% 46.39 47.27 46.02
Aug 14, 2024 45.74 0.61 1.35% 45.13 45.89 44.57

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Rhythm Pharma Company profile

About Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing treatment for genetic diseases of obesity, which are characterized by early-onset, severe obesity and an insatiable hunger (hyperphagia). Its lead product candidate, IMCIVREE (setmelanotide), is a potent melanocortin-4 receptor (MC4R). IMCIVREE is developed for the treatment of rare genetic diseases of obesity. It is focused on the melanocortin-4 receptor (MC4R) pathway, which is responsible for regulating weight and hunger. It targets the MC4R pathway to develop therapeutics for rare genetic diseases of obesity, including proopiomelanocortin (POMC) deficiency obesity, leptin receptor (LEPR) deficiency obesity, Bardet-Biedl syndrome (BBS), Alstrom syndrome, POMC or LEPR heterozygous deficiency obesity, Smith-Magenis syndrome, steroid receptor coactivator 1 (SRC1) deficiency obesity, MC4R deficiency obesity and SH2B adapter protein 1 (SH2B1) deficiency obesity.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Rhythm Pharmaceuticals Inc revenues increased from $0K to $3.2M. Net loss decreased 48% to $69.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Basic Earnings per Share excluding Extraordinary Items increased from -$3.04 to -$1.40.

Industry: Bio Therapeutic Drugs

222 Berkeley Street
12th Floor Boston
BOSTON
MASSACHUSETTS 02116
US

News

ECB Preview: cuts expected but the pace is uncertain

Markets expect the ECB to cut rates again in September, but how many more?

12:34, 11 September 2024

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

Introducing Newsquawk: your new in-platform newsfeed

We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.

14:09, 20 August 2024

Jackson Hole Preview: All eyes on Powell and Gold

The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.

15:24, 19 August 2024

All eyes on inflation: US and UK CPI take centre stage

Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.

14:41, 13 August 2024

European stocks face resistance in their attempt to recover

European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.

13:56, 9 August 2024

Global selloff continues on US economy fears

Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.

14:40, 5 August 2024

People also watch

US100

19,336.70 Price
+0.360% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

XRP/USD

0.57 Price
+5.030% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

57,821.00 Price
+0.430% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,551.74 Price
+1.660% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading